The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis

Xue Li, Peige Song, Jun Li, Yuchang Tao, Guowei Li, Xiumin Li, Zengli YuInternational Journal of Environmental Research and Public Health 2017 · DOI

TL;DR

This systematic review and meta-analysis provides the first comprehensive overview of Inflammatory Bowel Disease (IBD) burden and clinical characteristics in China. It reveals lower incidence rates compared to Western countries but highlights distinct demographic and clinical features, suggesting that IBD management strategies may need to be tailored for the Chinese population.

What Problem Does This Paper Address?

Inflammatory Bowel Disease (IBD), encompassing Crohn's Disease (CD) and Ulcerative Colitis (UC), is a group of chronic gastrointestinal disorders with a complex etiology involving genetic, environmental, and immune factors. While IBD prevalence is well-documented in North America and Europe, data from China has been sparse, hindering a global understanding of its epidemiology and clinical presentation. This lack of information makes it difficult to assess the true global disease burden and to adapt treatment approaches effectively for the Chinese population, which is undergoing rapid socioeconomic and lifestyle changes that may influence IBD development. This paper aims to fill this knowledge gap by systematically reviewing and synthesizing existing literature on IBD in China.

Methods

The researchers conducted a systematic review and meta-analysis of published literature on IBD in the Chinese population. They searched four databases (Medline, EMBASE, China National Knowledge Internet, and Wanfang) for studies published up to March 2016. Inclusion criteria focused on original studies reporting incidence, prevalence, or clinical characteristics of IBD in China, excluding systematic reviews and meta-analyses. Data extraction was performed by two independent authors, covering epidemiological and clinical aspects. For incidence rates, a meta-analysis was performed using random-effect or fixed-effect models depending on heterogeneity. Prevalence data, being less abundant, was analyzed descriptively. Clinical phenotypes and classifications were summarized using constituent ratios and 95% confidence intervals.

Datasets

The study did not introduce new datasets. Instead, it synthesized data from 47 publications that met the inclusion criteria. These publications provided epidemiological and clinical data on IBD cases in China.

Key Insights and Ideas

  • Growing Burden in China: Despite lower reported incidence rates than Western countries, the increasing urbanization and "westernization" of lifestyles in China suggest a rising IBD burden that may be underestimated.
  • Distinct Chinese IBD Profile: The study highlights significant differences in IBD characteristics between Chinese and Western populations, particularly in age of onset, sex distribution, and disease behavior.
  • Need for Localized Strategies: The observed differences underscore the importance of developing region-specific epidemiological data and clinical management guidelines for IBD in China, as Western-based approaches may not be directly applicable.
  • Geographic Heterogeneity: The incidence of IBD in China shows considerable regional variation, with higher rates observed in economically developed southeastern areas, suggesting a link to environmental and socioeconomic factors.

Key Results

  • Incidence Rates: The summary incidence rate for IBD in China was estimated at 1.74 per 100,000 person-years. Specifically, CD incidence was 0.40 per 100,000 person-years, and UC incidence was 1.18 per 100,000 person-years. These rates are considerably lower than those reported in European and American countries.
  • Sex Distribution: A male predominance was observed for both CD (sex ratio: 1.64) and UC (sex ratio: 1.29), which contrasts with some Western studies showing female predominance in CD.
  • CD Characteristics: The median age of CD diagnosis was 37.30 years, with the majority diagnosed between 17-40 years. Chinese CD patients were more likely to have non-stricturing and non-penetrating disease, with varied disease locations and fewer extra-intestinal manifestations (19.9%) compared to Western populations.
  • UC Characteristics: Chinese UC patients tended to be diagnosed later in life (median age 43.10 years), with a higher proportion experiencing moderate to severe disease courses. Segmental lesions were more common, and extra-intestinal manifestations were less prevalent (10.9%) than in Western cohorts.

Limitations and Future Work

The authors acknowledge that the study's reliance on hospital-based data may introduce bias, potentially leading to an underestimation of true incidence rates and an overestimation of disease severity. They emphasize the need for large-scale, population-based studies to further validate these findings and provide a more accurate picture of IBD in China. Future research should also focus on exploring the specific environmental and genetic determinants contributing to these observed differences in IBD presentation.

Summary updated

Abstract

The temporal trend of inflammatory bowel disease (IBD) incidence is reported to be increasing in worldwide regions; however, reports focusing on China are sparse. The aim of this study was to provide an overview of the disease burden and clinical features of IBD in the Chinese population. We searched Medline, EMBASE, and another two Chinese databases. A parallel literature review and data extraction were conducted. Meta-analysis was performed to estimate the summary incidence rate of Crohn's disease (CD) and ulcerative colitis (UC). The constituent ratios with 95% CI were calculated for clinical phenotypes and classifications. The literature review included 47 publications. The summary incidence rate of IBD was 1.74 (95% CI: 1.08; 2.40) per 100,000 person years, and the corresponding incidence rates of CD and UC were 0.40 (95% CI: 0.23; 0.57) and 1.18 (95% CI: 0.81; 1.56) per 100,000 person years, respectively. The sex distribution analysis indicated a male predominance in both CD (sex ratio: 1.64; 95% CI: 1.47-1.84) and UC (sex ratio: 1.29; 95% CI: 1.21-1.38). The clinical characteristics were summarized using data from 2283 CD cases and 17,958 UC cases; in which the majority of CD patients were diagnosed between 17-40 years of age, with non-stricturing and non-penetrating disease, varied disease locations, and less extra-intestinal manifestation. UC cases were featured with later disease diagnosis, a more severe disease course, more segmental lesions, and less extra-intestinal manifestations. Our study provided an estimated disease burden of IBD and demonstrated distinct clinical features in the Chinese population. Large-scale population-based studies are needed to further evaluate these findings.
BibTeX
@article{li2017disease,
  author = {Xue Li and Peige Song and Jun Li and Yuchang Tao and Guowei Li and Xiumin Li and Zengli Yu and Xiumin Li and Zengli Yu},
  title = {{The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis}},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2017},
  doi = {10.3390/ijerph14030238},
}
Figure